We believe that collaboration is the best way to succeed in our highly specialized sector. Kymos combines a genuinely flexible, personalized approach typical of smaller CROs, with the capacity to manage big-volume projects and most importantly, a robust network of certified, multidisciplinary partners built after years of successful collaboration: from preclinical and clinical trials to regulatory consulting, complementary testing, formulation, logistics, academia as well as EU market access solutions for foreign pharma clients. Whatever your needs, you can count on Kymos as your reliable one-stop-shop provider.

Our Clinical Partners

A multinational array of FDA-inspected CROs and clinical units for study design, clinical trials, bioequivalences, tolerability and other expert clinical solutions for small and large molecules, IMPs and generics.

Our Pre-Clinical Partners

Preclinical studies with key animal models including rodents, rabbits, dogs, cats, minipigs, non-human primates and livestock. Solutions for both human and veterinary DPs and residue depletion studies.

Our Regulatory Partners

Consulting services for medical, regulatory and pharmacovigilance affairs from early development until post-commercialization, systems and process validation, GMP compliance audits, preparation for FDA and EMA inspections and global scientific support.

Our Logistic Partners

Sourcing, distribution, logistics and wholesale comprehensive services including warehousing, EU depot and shipment, global supply of comparators, early access programs, procurement of trial medication and other logistic solutions.

Our Academic Partners

R&D support, scientific advice, facilities and instruments for specialty assays and lifecycle management of our service portfolio.

Our Testing Partners

Integrated solutions for custom synthesis, chemical R&D, crystallization optimization, solid form identification and other testing services for early-phase drug discovery.

Our Formulation Partners

Experimental support in human and animal health solid form characterization, R&D and development of formulations, drug delivery systems and medical devices, as well as consulting services.

Our Market Partners

Outsourcing services for marketing, B2B business development, market access, in-licensing, out-licensing and alliance management for close-to-market products.

Our networks

Find out more about our Services

Get in touch

  • KOREA PHARM & BIO: Goyang, KR | 23-26 Apr 2024

  • BIO KOREA 2024: Seoul, KR | 08-10 May 2024

  • BIO International Convention: San Diego, US | 3-6 Jun 2024

  • Congrès POLEPHARMA Biotesting: Évreux, FR | 5-6 Jun 2024

  • AFI Symposium: Rimini, IT | 5-7 Jun 2024

  • BIOPLUS – INTERPHEX KOREA: Seoul, KR | 10-12 Jul 2024

  • Farmaforum: Madrid, ES | 25-26 Sep 2024

  • Biomarkers Europe 2024: Basel, CH | 30 Sep – 01 Oct 2024

  • CPHI 2024: Milan, IT | 8-10 Oct 2024

  • BIO-Europe Autumn: Stockholm, SE | 4-6 Nov 2024

  • European Bioanalysis Forum: Barcelona, ES | 20-22 Nov 2024

  • TIDES Europe: Hamburg, DE | 12-14 Nov 2024

  • PharmaLab Congress: Düsseldorf, DE | 25-27 Nov 2024

  • I4ID 2024: Lyon, FR | 27-28 Nov 2024


    logo of Kymos


    logo of Prolytic


    logo of Pharmaprogress






    logo of Kymos for KR branch